Clinical trial
Assessment of the Safety and Effectiveness of a Micro Radiofrequency Skin Treatment Device (nebulyft)
NCT06623214 is registered in ClinicalTrials.gov with Hangzhou Rebecca Medical Science and Technology Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Safety and Effectiveness of a Micro Radiofrequency Skin Treatment Device (nebulyft)
- Lead sponsor
- Hangzhou Rebecca Medical Science and Technology Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 7, 2024
- Completion date
- August 13, 2024
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wrinkle reduction